Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $5,000 | -68.8% | 393 | -68.1% | 0.00% | -50.0% |
Q1 2017 | $16,000 | -68.0% | 1,231 | -65.9% | 0.00% | -71.4% |
Q4 2016 | $50,000 | -99.5% | 3,612 | -99.5% | 0.01% | -99.5% |
Q3 2016 | $10,254,000 | -3.5% | 659,892 | -3.1% | 1.47% | -7.1% |
Q2 2016 | $10,624,000 | +12.9% | 681,170 | -3.6% | 1.58% | +19.4% |
Q1 2016 | $9,409,000 | -6.0% | 706,680 | +1.6% | 1.33% | -5.7% |
Q4 2015 | $10,013,000 | +86.9% | 695,666 | +67.5% | 1.41% | +75.6% |
Q3 2015 | $5,358,000 | -3.9% | 415,359 | +6.2% | 0.80% | +7.7% |
Q2 2015 | $5,577,000 | -10.5% | 390,951 | +2.9% | 0.74% | -14.9% |
Q1 2015 | $6,234,000 | +15.1% | 380,011 | -1.3% | 0.88% | +17.8% |
Q4 2014 | $5,414,000 | +0.2% | 384,899 | +6.1% | 0.74% | -5.1% |
Q3 2014 | $5,402,000 | +3.6% | 362,864 | -8.5% | 0.78% | +7.4% |
Q2 2014 | $5,212,000 | +3.2% | 396,665 | -6.6% | 0.73% | +1.4% |
Q1 2014 | $5,050,000 | +0.5% | 424,879 | +25.3% | 0.72% | -0.6% |
Q4 2013 | $5,024,000 | +19.7% | 339,011 | +2.9% | 0.72% | +18.7% |
Q3 2013 | $4,197,000 | -3.3% | 329,446 | +2.9% | 0.61% | -12.6% |
Q2 2013 | $4,342,000 | – | 320,050 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
THOMAS WHITE INTERNATIONAL LTD | 339,011 | $5,024,000 | 0.72% |
GRATRY & Co LLC | 83,750 | $1,243,000 | 0.41% |
GlobalBridge, Inc. | 14,392 | $213,000 | 0.11% |
Aperio Group, LLC | 454,127 | $6,729,000 | 0.10% |
ZEVIN ASSET MANAGEMENT LLC | 18,581 | $276,000 | 0.08% |
ETRADE Capital Management LLC | 63,601 | $942,000 | 0.07% |
PARAMETRIC PORTFOLIO ASSOCIATES LLC | 411,463 | $6,106,000 | 0.02% |
PRIVATE TRUST CO NA | 456 | $7,000 | 0.00% |
First Horizon Advisors, Inc. | 290 | $4,000 | 0.00% |
AMERIPRISE FINANCIAL INC | 10,929 | $163,000 | 0.00% |